secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASENSUS SURGICAL, INC. (—)
CIK:        0000876378
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001437749-24-017096
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Asensus Surgical receives non-binding acquisition proposal from KARL STORZ at $0.35/share; Q1 revenue $1.1M
--------------------------------------------------------------------------------

- KARL STORZ proposes to acquire 100% of Asensus for $0.35/share cash; 10-week exclusivity period for due diligence.
- KARL STORZ provides up to $20M secured loan; $7M drawn to date to support operations during exclusivity.
- Q1 2024 revenue $1.1M (vs $1.0M Q1 2023); net loss $22.5M ($0.08 loss per share).
- Cash and short-term investments $8.0M at March 31, 2024; low liquidity position.
- Nearly 900 procedures performed globally in Q1; one new Senhance program initiated YTD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/0001437749-24-017096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876378/000143774924017096/asxc20240514_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-017096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer